BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35354789)

  • 1. METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.
    Wang Y; Chen J; Gao WQ; Yang R
    Cell Death Discov; 2022 Mar; 8(1):143. PubMed ID: 35354789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism.
    Hou X; Li Y; Song J; Peng L; Zhang W; Liu R; Yuan H; Feng T; Li J; Li W; Zhu C
    Hepatol Commun; 2023 Aug; 7(8):. PubMed ID: 37534933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
    Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
    Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
    Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanism.
    Wang J; Yin H; Li G; Wu D; Xu Y; Chen Y; Wang X; Xing Y; Zhang T; Fei D; Yang P; Fang F; Tao Y; Li X; Yu J; Yang Y; Li Z; Shi L; Zhang Z; Pan J
    Cell Death Discov; 2024 Apr; 10(1):186. PubMed ID: 38649363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer.
    Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J
    J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14 is decreased and regulates m
    He H; Zhang Q; Liao J; Lei J; Luo M; Huang J; Chen M; Shen Y; Wang J; Xu P; Xiao Y
    J Neurochem; 2023 Aug; 166(3):609-622. PubMed ID: 37309980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner.
    Lu J; Yu L; Xie N; Wu Y; Li B
    J Cancer; 2023; 14(7):1117-1131. PubMed ID: 37215454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL14 promotes proliferation, migration, and invasion in endometriotic stromal cell growth by activating the ZEB1/MEK/ERK pathway.
    Lv X; Li F
    Gynecol Obstet Invest; 2024 Jun; ():. PubMed ID: 38934184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.
    Zhang L; Li Y; Zhou L; Zhou H; Ye L; Ou T; Hong H; Zheng S; Zhou Z; Wu K; Yan Z; Thiery JP; Cui J; Wu S
    Cancer Res; 2023 Jun; 83(11):1834-1850. PubMed ID: 36939388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.
    Yao Q; He L; Gao X; Tang N; Lin L; Yu X; Wang D
    Front Oncol; 2021; 11():699749. PubMed ID: 34476213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL14 Suppresses Tumor Stemness and Metastasis of Colon Cancer Cells by Modulating m6A-Modified SCD1.
    Xu D; Han S; Yue X; Xu X; Huang T
    Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37592151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.
    Ren S; Xiao Y; Yang L; Hu Y
    Thorac Cancer; 2023 Jan; 14(3):254-266. PubMed ID: 36448247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of METTL14 mediates the elevation of PERP mRNA N
    Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
    Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.
    Yin L; Ma C; Hou S; Ma X
    Bioengineered; 2022 Mar; 13(3):4773-4785. PubMed ID: 35139773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
    Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
    Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M6A "Writer" Gene
    Cai C; Long J; Huang Q; Han Y; Peng Y; Guo C; Liu S; Chen Y; Shen E; Long K; Wang X; Yu J; Shen H; Zeng S
    Front Oncol; 2021; 11():615296. PubMed ID: 34221955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.